Dr. Stefan Hund

CEO Evoleen Ventures at Evoleen

Dr. Stefan Hund has an extensive work experience that spans from 2004 to the present. In 2004, they began working as a Senior Associate at PricewaterhouseCoopers (PwC) where they developed from Associate to Senior Associate in the field of auditing. In 2006, they moved to Arthur D. Litte where they developed from Associate to Consultant to Senior Consultant to Manager in the global strategy consultancy. From 2011 to 2019, they worked at Hilti, beginning as Division Manager/Sales Director and eventually becoming Head of Power Segment and Head of Nuclear Power. In 2019, they took on the role of CEO at TRI Dental Implants Int. AG. In 2021, they became a Member of YPO and Managing Director MedTech Vertical at evoleen. Finally, in 2022, they were appointed President of the Board and Interim CEO at Collabree AG.

Dr. Stefan Hund began their education in 1997, when they enrolled at Karlsruhe Institute of Technology (KIT) and earned a Diplom Wirtschaftsingenieur in Wirtschaftswissenschaften in 2002. In 2001, they also completed a Diplom Wirtschaftsingenieur at the University of Newcastle in Business. Afterward, they attended Vienna University of Economics and Business, where they earned a Doctor in PhD studies in 2004. Most recently, they attended IMD in 2021 and earned a High Performance Leadership degree.

Links

Previous companies

Hilti logo
PwC logo

Timeline

  • CEO Evoleen Ventures

    December, 2021 - present